| IOVA |    | Iovance Biotherapeutics, Inc. - Common Stock | | | -3.75% -3.75% 0 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1425205/000110465924043158/0001104659-24-043158-index.htm
8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer) | + My List |
| CNTB | | Connect Biopharma Holdings Limited - American Depositary Shares | | | -1.32% -1.32% 0 | | + Biopharma, Country: China, T cell-based
Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1835268/000183526824000012/0001835268-24-000012-index.htm
6-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | + My List |
| LVTX | | LAVA Therapeutics N.V. - Ordinary Shares | | | -4.24% -4.24% 0 | | + T cell-based, Cancer fight, Medicine, Disease: Oncology
Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1840748/000155837024003667/0001558370-24-003667-index.htm
6-K - LAVA Therapeutics NV (0001840748) (Filer) | + My List |
| BTMD | | Biote Corp. - Class A common stock | | | 3.86% 3.86% 0 | | + T cell-based, Biotechnology, Immunology, Medicine
| + My List |
